Comunicati Stampa
Salute e Benessere

Eurobio Scientific: EB Development rises above 90% threshold

EB Development rises above 90% thresholdParis, May 19, 2024 – 7:00 pm - Eurobio Scientific(FR0013240934, ALERS, PEA-PME eligible), a leading French group inin vitromedical diagnostics and life sciences, was informed today by EB Development that it had exceeded the threshold of 90% of the company's share capital. This threshold crossing results from the acquisition by EB Development of Eurobio Scientific shares on the market.EB Development now holds 9,224,652 shares, or 90...
LES ULIS, (informazione.news - comunicati stampa - salute e benessere)

EB Development rises above 90% threshold

Paris, May 19, 2024 – 7:00 pm - Eurobio Scientific (FR0013240934, ALERS, PEA-PME eligible), a leading French group in in vitro medical diagnostics and life sciences, was informed today by EB Development that it had exceeded the threshold of 90% of the company's share capital. This threshold crossing results from the acquisition by EB Development of Eurobio Scientific shares on the market.

EB Development now holds 9,224,652 shares, or 90.01% of Eurobio Scientific's share capital and 90.01% of its voting rights.

Next financial meeting
Annual General Meeting: June 19, 2025


Attachment


Per maggiori informazioni
Sito Web
diaxonhit.com
Ufficio Stampa
 Nasdaq GlobeNewswire (Leggi tutti i comunicati)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti
Allegati
Non disponibili